Dihydroergotamine US-PARA IV - FDF

Active Ingredient
Trade Name Rld
Dosage Form
Strength
Unit
Nda No
Date Of Para Iv Submission
Number Of Andas Submitted
180 Day Exclusivity Status
180 Day Decision Posting Date
Date Of First Anda Approval
Date Of First Commercial Marketing By Ftf
Expiration Date Of Last Qualifying Patent
Last Update : 2001 To Aug 2024